Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Key highlights Retatrutide is a next-generation weight loss medication that activates GLP-1, GIP, and glucagon receptors simultaneously to promote appetite suppression, improve metabolic health, and increase energy expenditure
According to researchers from the University of Pennsylvania and Cedars-Sinai Medical Center, the number of non-diabetic patients starting these medications jumped from 21,000 in 2019 to over 174,000 in 2023
Patients should seek medical advice if they experience symptoms of thyroid dysfunction despite treatment, or if they develop concerning symptoms such as difficulty swallowing, voice changes, or a rapidly enlarging neck mass
Phase 2 liver disease data published in Nature Medicine (2024) identifies retatrutide as the compound with the most comprehensive hepatic fat reduction profile currently under clinical investigation, making it the correct peptide for NAFLD and MASH preclinical study designs
US$ 28.85
US$ 24.87
US$ 21.52
US$ 28.66
US$ 26.46
US$ 25.02
US$ 29.26
US$ 26.98
US$ 29.78
US$ 27.90
US$ 23.85
US$ 26.88
